FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Macleods Pharma Losartan Potassium and Hydrochlorothiazide Recall

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12

MACLEODS PHARMA USA, INC · Princeton, NJ

Risk level
Class II
Reported by FDA
May 22, 2024
Recall ID
D-0498-2024
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Losartan Potassium and Hydrochlorothiazide starting May 7, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0498-2024 on May 22, 2024. Reason: Presence of foreign substance: plastic-like substance. Status: Ongoing.

Why it was recalled

Presence of foreign substance: plastic-like substance.

Product description

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44

Lot numbers, UPCs & expiration codes

Lot #: BLK2304A, Exp. 07/31/2025

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0498-2024
Classification
Class II
Status
Ongoing
Recall initiated
May 7, 2024
FDA report date
May 22, 2024
Quantity
1,048 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
MACLEODS PHARMA USA, INC

Original FDA data

Every field from FDA enforcement report D-0498-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
94592
Address
103 College Rd E Fl 2
Code information
Lot #: BLK2304A, Exp. 07/31/2025
Postal code
08540-6611
Report date
May 22, 2024
Product type
Drugs
Recall number
D-0498-2024
Classification
Class II
Recalling firm
MACLEODS PHARMA USA, INC
Product quantity
1,048 bottles
Reason for recall
Presence of foreign substance: plastic-like substance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
Distribution pattern
USA Nationwide
Recall initiation date
May 7, 2024
Center classification date
May 15, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0498-2024, published May 22, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls